Skip to content

MDMA research published in 2011

Page 2 of 7: studies 21 to 40 of 125, newest first. Back to the MDMA overview

Studies

The relationships of ‘ecstasy’ (MDMA) and cannabis use to impaired executive inhibition and access to semantic long‐term memory

Human Psychopharmacology Clinical and Experimental September 7, 2011 Philip N. Murphy, Philip G. Erwin, L. Maciver et al. 9 citations

This study aimed to examine the relationship between the consumption of ecstasy (3,4-methylenedioxymethamphetamine (MDMA)) and cannabis, and performance on the random letter generation task which generates dependent variables drawing upon executive inhibition and access to semantic long-term memory (LTM). The participant group was a between-participant independent variable with users of both...

( )-3,4-Methylenedioxymethamphetamine and Metabolite Disposition in Plasma and Striatum of Wild-Type and Multidrug Resistance Protein 1a Knock-Out Mice

Journal of Analytical Toxicology September 1, 2011 Karl B. Scheidweiler, Bruce Ladenheim, Allan J. Barnes et al. 10 citations

Mice lacking multidrug resistance protein 1a (mdr1a) are protected from methylenedioxymethamphetamine (MDMA)-induced neurotoxicity, suggesting mdr1a might play an important role in this phenomenon. We characterized MDMA pharmacokinetics in murine plasma and brain to determine if mdr1a alters MDMA distribution. Wild-type (mdr1a⁺/⁺) and mdr1a knock-out (mdr1a⁻/⁻) mice received i.p. 10, 20 or 40...

MDMA (ecstasy) enhances loud noise-induced morphofunctional alterations in heart and adrenal gland.

Microscopy research and technique September 2011 Federica Fulceri, Michela Ferrucci, Paola Lenzi et al.

Noise is an environmental stressor increasingly more present in modern life and, in particular, in a variety of recreational contexts. The aim of this work is to show the effects of noise on the myocardium and adrenal gland, through a careful review of the literature dealing with the peripheral effects of noise exposure in experimental and clinical studies. Noise induces adverse effects in...

DOI: 10.1002/jemt.20971 (opens in new tab) Full text (opens in new tab) Amphetamine derivatives Catecholamine Environmental stress Myocardium +1

Influences of activity wheel access on the body temperature response to MDMA and methamphetamine.

Pharmacology, Biochemistry, and Behavior September 2011 N W Gilpin, M J Wright, G Dickinson et al.

Recreational ingestion of the drug 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") can result in pathologically elevated body temperature and even death in humans. Such incidents are relatively rare which makes it difficult to identify the relative contributions of specific environmental and situational factors. Although animal models have been used to explore several aspects of...

"Ecstasy" associated deaths: what is a fatal concentration ? Analysis of a case series.

Forensic science, medicine, and pathology September 2011 C M Milroy

Amphetamine derivative drugs, particularly 3,4-methylenedioxymethamphetamine (MDMA), commonly known as ecstasy, are popular recreational drugs. MDMA is associated with causing death by a number of mechanisms, including hyperpyrexia, cardiac arrhythmia water intoxication and liver failure. Seventy-seven deaths where MDMA was detected in body fluids/organs were reviewed. Of these cases 59 deaths...

Special issue on illicit drugs

Drug Testing and Analysis September 1, 2011 Simon D. Brandt 5 citations

The agony and the ecstasy associated with the area of illicit drugs is a matter of constant interest today. Prevalence of use, availability of reference standards, and novel detection methods provide many challenging and exciting opportunities, particularly when dealing with increasing levels of novelty and complexity within a globalized world. This special issue aims to present a snapshot of a...

DOI: 10.1002/dta.308 (opens in new tab) Ecstasy Variety cybernetics Drugs of abuse Recreational drug +7

Changes in interleukin-1 signal modulators induced by 3,4-methylenedioxymethamphetamine (MDMA): regulation by CB2 receptors and implications for neurotoxicity

Journal of Neuroinflammation August 6, 2011 O'Shea Esther, Rubio Ana, Mayado Andrea et al. 28 citations

Abstract Background 3,4-Methylenedioxymethamphetamine (MDMA) produces a neuroinflammatory reaction in rat brain characterized by an increase in interleukin-1 beta (IL-1β) and microglial activation. The CB2 receptor agonist JWH-015 reduces both these changes and partially protects against MDMA-induced neurotoxicity. We have examined MDMA-induced changes in IL-1 receptor antagonist (IL-1ra)...

Novel object recognition memory: measurement issues and effects of MDMA self-administration following short inter-trial intervals.

Journal of Psychopharmacology August 2011 Susan Schenk, David N. Harper, Jennifer Do

The present study was undertaken to examine effects of self-administered MDMA on novel object exploration (NOR) memory. Self-administration was conducted during daily 2 h tests that continued until a total of 165 mg/kg was self-administered (range = 13-41 days for individual rats). Control rats were placed in the self-administration boxes during daily sessions but did not receive any drug. One...

Rats preexposed to MDMA display attenuated responses to its aversive effects in the absence of persistent monoamine depletions.

Psychopharmacology August 2011 Daniel L Albaugh, Jennifer A Rinker, Michael H. Baumann et al.

The abuse potential of a given drug may be mediated by both its rewarding and aversive effects, the latter of which are often far less characterized. Using the conditioned taste-aversion (CTA) preparation, the present experiments examined changes in the aversive effects of the commonly used recreational drug MDMA following repeated drug exposures. Experiment 1 used three varying doses of MDMA...

Event related potential (ERP) evidence for selective impairment of verbal recollection in abstinent recreational methylenedioxymethamphetamine (“Ecstasy”)/polydrug users

Psychopharmacology August 1, 2011 Adrian P. Burgess, Louise Venables, Helena Jones et al. 26 citations

Objectives Ecstasy is a recreational drug whose active ingredient, 3,4-methylenedioxymethamphetamine (MDMA), acts predominantly on the serotonergic system. Although MDMA is known to be neurotoxic in animals, the long-term effects of recreational Ecstasy use in humans remain controversial but one commonly reported consequence is mild cognitive impairment particularly affecting verbal episodic...

A Perhaps Unexpected Role of Norepinephrine in Actions of MDMA

Clinical Pharmacology & Therapeutics July 20, 2011 Thomas F. Newton 9 citations

In this issue, Hysek and colleagues present new data describing the impact of treatment with reboxetine on the effects produced by 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in human volunteers. They demonstrate that several effects of MDMA are mediated by reboxetine's actions on norepinephrine (NE) transporters, an unexpected finding. Building on earlier work, their new data provide...

The effects of mirtazapine and fluoxetine on hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.

Neuroscience Letters July 15, 2011 Makiko Kasai, Katsutoshi Shioda, Koichi Nisijima et al.

The use of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") as a recreational drug has spread worldwide. Fatal hyperthermia is a likely side effect of using MDMA in combination with monoamine oxidase inhibitors. However, most antidepressants do not pose a high risk of developing hyperthermia when used in conjunction with MDMA. Mirtazapine is a novel antidepressant and a potent 5-HT(2A)...

Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): Neurodegeneration versus Neuromodulation

Pharmaceuticals July 5, 2011 Elena Puerta, Norberto Aguirre 6 citations

The amphetamine analogue 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’) is widely abused as a recreational drug due to its unique psychological effects. Of interest, MDMA causes long-lasting deficits in neurochemical and histological markers of the serotonergic neurons in the brain of different animal species. Such deficits include the decline in the activity of tryptophan hydroxylase in...

Sleep apnea in young abstinent recreational MDMA (“ecstasy”) consumers

Neurology July 4, 2011 Una D. Mccann, Francis P. Sgambati, Alan R. Schwartz et al. 1 citation

Background: Methylenedioxymethamphetamine (MDMA, "ecstasy") is a popular recreational drug of abuse and a selective brain serotonin neurotoxin.Functional consequences of MDMA neurotoxicity have defied ready characterization.Obstructive sleep apnea (OSA) is a common form of sleep-disordered breathing in which brain serotonin dysfunction may play a role.The present study sought to determine...

A Caenorhabditis elegans p38 MAP kinase pathway mutant protects from dopamine, methamphetamine, and MDMA toxicity.

Neuroscience Letters July 1, 2011 Matthew A Schreiber, Steven L McIntire

Biogenic amine systems are damaged by amphetamine abuse and in Parkinson's disease. The mechanisms mediating this damage are of high importance because of the public health impact of these problems. Here we have taken advantage of the Caenorhabditis elegans nematode model system to investigate genetic modifiers of biogenic amine toxicity. In a forward genetic screen, we identified a mutant...

[Ambient temperature impact on hepatocellular liver damage in rats following intake of 3,4-methylenedioxymethamphetamine].

Vojnosanitetski Pregled July 2011 Nadica S Marinković, Zivorad Malicevic, Jovan Dimitrijević

3,4-methylendioxymethamphetamine (MDMA, Ecstasy) is a psycho-stimulating agent. It is usually taken orally in the form of tablets. It is absorbed throught the gastrointestinal mucous membrane. Hyperthermia is the most prominent clinical sign of MDMA intake. The most prominent forensic finding of lethal MDMA poisoning is myocardial infarction and cerebrovascular bleeding. However, liver and...